Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L van Riel

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
British Journal of Rheumatology|April 1, 1993
Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysisM J Wijnands, M A Van 'T Hof, L B Van De Putte, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology ResearchD L Scott, G S Panayi, P L van Riel, et al.
Rheumatology (Oxford, England)|June 17, 1999
Familial aggregation of rheumatoid arthritis in The Netherlands: a cross-sectional hospital-based survey. European Consortium on Rheumatoid Arthritis families (ECRAF)P Barrera, T R Radstake, J M Albers, et al.
Arthritis and Rheumatism|August 14, 1999
No support for HLA-DQ encoded susceptibility in rheumatoid arthritisN de Vries, C van Elderen, H Tijssen, et al.
Annals of the Rheumatic Diseases|August 1, 1995
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective studyM A van Leeuwen, J Westra, P C Limburg, et al.
Arthritis and Rheumatism|October 11, 2001
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritisP M Welsing, A M van Gestel, H L Swinkels, et al.
Annals of the Rheumatic Diseases|January 1, 1995
Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluidM A van Leeuwen, J Westra, P C Limburg, et al.
The Journal of Rheumatology|March 1, 1993
Development of a disease activity score based on judgment in clinical practice by rheumatologistsD M van der Heijde, M van 't Hof, P L van Riel, et al.
Annals of the Rheumatic Diseases|October 1, 1990
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineM J Wijnands, W A Allebes, A M Boerbooms, et al.
Seminars in Arthritis and Rheumatism|October 1, 1994
Second-line treatment in seronegative spondylarthropathiesM C Creemers, P L van Riel, M J Franssen, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Rheumatology|April 1, 1993
Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysisM J Wijnands, M A Van 'T Hof, L B Van De Putte, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology ResearchD L Scott, G S Panayi, P L van Riel, et al.
Rheumatology (Oxford, England)|June 17, 1999
Familial aggregation of rheumatoid arthritis in The Netherlands: a cross-sectional hospital-based survey. European Consortium on Rheumatoid Arthritis families (ECRAF)P Barrera, T R Radstake, J M Albers, et al.
Arthritis and Rheumatism|August 14, 1999
No support for HLA-DQ encoded susceptibility in rheumatoid arthritisN de Vries, C van Elderen, H Tijssen, et al.
Annals of the Rheumatic Diseases|August 1, 1995
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective studyM A van Leeuwen, J Westra, P C Limburg, et al.
Arthritis and Rheumatism|October 11, 2001
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritisP M Welsing, A M van Gestel, H L Swinkels, et al.
Annals of the Rheumatic Diseases|January 1, 1995
Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluidM A van Leeuwen, J Westra, P C Limburg, et al.
The Journal of Rheumatology|March 1, 1993
Development of a disease activity score based on judgment in clinical practice by rheumatologistsD M van der Heijde, M van 't Hof, P L van Riel, et al.
Annals of the Rheumatic Diseases|October 1, 1990
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineM J Wijnands, W A Allebes, A M Boerbooms, et al.
Seminars in Arthritis and Rheumatism|October 1, 1994
Second-line treatment in seronegative spondylarthropathiesM C Creemers, P L van Riel, M J Franssen, et al.
Pageof 15